CmaxInsight Market Intelligence: Market Research Reports

... 1-2 Business Days. CmaxInsight’s, “Angiotensin Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Angiotensin Receptor Agonist. Pipeline Covered: This section mentions all the ...

... within 1-2 Business Days. CmaxInsight’s, “Anti GM-CSF Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the Anti GM-CSF Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD152 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD152 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD19 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD19 Antibody. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Anti-CD274 (PD-L1) Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Anti-CD274 (PD-L1) Antibody. Pipeline Covered: This section mentions all the ...

... 1-2 Business Days. CmaxInsight’s, “Anti-CD279 (PD-1) Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Anti-CD279 (PD-1) Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD28 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD28 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD3 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD3 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD33 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD33 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD37 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD37 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD38 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD38 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD40 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD40 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD52 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD52 Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-CD80 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-CD80 Antibody. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Anti-Dickkopf-1 (Dkk-1) Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Anti-Dickkopf-1 (Dkk-1) Antibody. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Anti-Lymphotoxin-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Anti-Lymphotoxin. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Anti-Mucin 1 (MUC1) Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Anti-Mucin 1 (MUC1) Antibody. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Apolipoprotein B (ApoB) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Apolipoprotein B (ApoB) Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Apoptosis Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Apoptosis Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Arginine Depletors-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Arginine Depletors. Pipeline Covered: This section mentions all the promising ...

... delivered to the clients within 1-2 Business Days. CmaxInsight’s, “ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor-Pipeline ... strategies by identifying potential partners with progressing projects for ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or ...

... within 1-2 Business Days. CmaxInsight’s, “ATPase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the ATPase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Aurora Kinase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Aurora Kinase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Autophagy modulators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the Autophagy modulators. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “B-Cell Activating Factor (BAFF) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence B-Cell Activating Factor (BAFF) Inhibitor R&D Please note: Certain sections in the ...

... 1-2 Business Days. CmaxInsight’s, “Bcl-xL Protein Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Bcl-xL Protein Inhibitor. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Bcr-Abl Tyrosine Kinase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Bcr-Abl Tyrosine Kinase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Benzodiazepine Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Benzodiazepine Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Beta Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta Receptor Agonist. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “Beta Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Beta Secretase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta Secretase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Beta Selective Thyroid Hormone Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Beta Selective Thyroid Hormone Receptor Agonist to enhance and expand business ...

... 1-2 Business Days. CmaxInsight’s, “Beta-1 Receptors Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta-1 Receptors Antagonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Beta-1 Receptors Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta-1 Receptors Agonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Beta-2 Receptors Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta-2 Receptors Antagonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Beta-2 Receptors Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta-2 Receptors Agonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Beta-3 Receptors Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Beta-3 Receptors Agonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Beta-Lactamase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Beta-Lactamase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Blood Coagulation Factor Activators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Blood Coagulation Factor Activators. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Bradykinin Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Bradykinin Antagonist. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Bradykinin Receptor B1 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Bradykinin Receptor B1 Antagonist. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Bradykinin Receptor B2 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Bradykinin Receptor B2 Antagonist. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors-Pipeline Intelligence, 2019”, report ... potential partners with progressing projects for BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors to enhance and ...

... clients within 1-2 Business Days. CmaxInsight’s, “Broad Spectrum Chemokine Inhibitor (BSCIs)-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Broad Spectrum Chemokine Inhibitor (BSCIs) R&D Please note: Certain sections in ...

... clients within 1-2 Business Days. CmaxInsight’s, “Brutons Tyrosine Kinase (Btk) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Brutons Tyrosine Kinase (Btk) Inhibitor R&D Please note: Certain sections in the ...

... Business Days. CmaxInsight’s, “C1 Esterase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the C1 Esterase Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “C5a Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the C5a Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonist to enhance and expand business ...

... within 1-2 Business Days. CmaxInsight’s, “Cannabinoid Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Cannabinoid Agonist. Pipeline Covered: This section mentions all the promising ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Cannabinoid Receptor Type 1 (CB1) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Cannabinoid Receptor Type 1 (CB1) Antagonist to enhance and expand business potential ...